Inulin And Sodium Chloride

(Inulin)

ApprovedSmall molecule

Inulin And Sodium Chloride is one of 72 small molecule programs targeting Knee Osteoarthritis. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

FDA Application

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

Knee OsteoarthritisNot yet recruiting

Cystic FibrosisActive, not recruiting

DiabetesNot yet recruiting

Knee OsteoarthritisPhase 2

Not yet recruiting

Cystic FibrosisApproved

Active, not recruiting

DiabetesApproved

Not yet recruiting

Competition

Competitive Landscape

107 competitors in Cystic Fibrosis

#DrugCompanyPhaseTrials

Inulin And Sodium Chloride

BBlue Earth Diagnostics

Approved

1 2

Ibsrela

AArdelyx

Phase 3

1 3

Biaxin

AbbVie

Phase 2

2 4

Zyvox

Pfizer

Phase 2

2 5

Lamprene

Novartis

Phase 2

1 6

HSK31858

Haisco Pharmaceutical Group Co., Ltd.

Phase 3

2 7

Sirturo

WWim Janssens

Phase 2

1 8

ELX/TEZ/IVA

Vertex Pharmaceuticals

Phase 3

18 9

Trikafta

NNottingham University Hospitals NHS Trust

Phase 3

4 10

VNZ/TEZ/D-IVA

Vertex Pharmaceuticals

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Post-ApprovalNot yet recruiting

Diabetes

NCT04698330

Q2 2027

Phase 2Recruiting

Asthma

NCT06372249

Q3 2027

Phase 2Not yet recruiting

Knee Osteoarthritis

NCT07189585

Clinical

Trials by Indication[1]

Diabetes1 trial

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

Not yet recruiting·SSecond Xiangya Hospital of Central South University·Phase 4·NCT04698330·240 enrolled

Function1 trial

Evaluation of New Markers to Assess Kidney Function

Withdrawn·TTufts Medical Center··NCT00938561

Metastatic Colorectal Cancer1 trial

Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer

Unknown status·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 1·NCT06347198·30 enrolled

Cystic Fibrosis1 trial

Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis

Completed·EEmory University·Phase 4·NCT04118010·40 enrolled

Hemodynamic1 trial

Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters

Completed·MMedical University of Vienna·N/A·NCT00431665·9 enrolled

4 more indications

Asthma1 trial

A Clinical Trial of Soluble Fiber for Asthma

Recruiting·PPhoenix Children's Hospital·Phase 2·NCT06372249·105 enrolled

Familial adenomatous polyposis1 trial

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Unknown status·RRadboud University Medical Center·Phase 2·NCT00319007·30 enrolled

Intensive Care Unit1 trial

Inulin for Infections in the Intensive Care Unit

Completed·—·Phase 2·NCT03865706·94 enrolled

Knee Osteoarthritis1 trial

Change in LPS With Inulin Supplementation and Its Association With Knee Pain Among Older Adults With Osteoarthritis

Not yet recruiting·YYale University·Phase 2·NCT07189585·84 enrolled

Regulatory

FDA Approval Timeline[4]

Jan 1, 1982

INULIN AND SODIUM CHLORIDE

NDA NDA002282

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for Inulin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Inulin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Inulin. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA002282). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Blue Earth Diagnostics company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: BBlue Earth Diagnostics

Inulin And Sodium Chloride

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q2 2027

Q3 2027

Trials by Indication[1]

Diabetes1 trial

Function1 trial

Metastatic Colorectal Cancer1 trial

Cystic Fibrosis1 trial

Hemodynamic1 trial

Asthma1 trial

Familial adenomatous polyposis1 trial

Intensive Care Unit1 trial

Knee Osteoarthritis1 trial

FDA Approval Timeline[4]

References

Drug Info

Quick Facts

Related News